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Abstract
Background: Axin1 and its homolog Axin2 are scaffold proteins essential for regulating Wnt signaling. Axin-dependent
regulation of Wnt is important for various developmental processes and human diseases. However, the involvement of
Axin1 and Axin2 in host defense and inflammation remains to be determined.
Methods/Principal Findings: Here, we report that Axin1, but not Axin2, plays an essential role in host-pathogen interaction
mediated by the Wnt pathway. Pathogenic Salmonella colonization greatly reduces the level of Axin1 in intestinal epithelial
cells. This reduction is regulated at the posttranslational level in early onset of the bacterial infection. Further analysis reveals
that the DIX domain and Ser614 of Axin1 are necessary for the Salmonella-mediated modulation through ubiquitination and
SUMOylation.
Conclusion/Significance: Axin1 apparently has a preventive effect on bacterial invasiveness and inflammatory response
during the early stages of infection. The results suggest a distinct biological function of Axin1 and Axin2 in infectious
disease and intestinal inflammation while they are functionally equivalent in developmental settings.
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Introduction
Axin1 and 2 belong to the Axin family, a negative regulator of
the Wnt signaling pathway and a key player in developmental
processes and pathogenesis of human diseases [1,2,3,4]. Axin
forms a complex with GSK-3b an b-catenin and promotes GSK-
3b-dependent phosphorylation of b-catenin [5,6,7]. In normal
cells, b-catenin levels are kept low through interactions with GSK-
3b, APC, and Axin [8,9,10,11]. Dishevelled (Dsh) is the upstream
regulator of the b-catenin pathway. At the C-terminal end, Axin
can bind with Dsh and this interaction reduces b-catenin binding
[8,9,10,11]. Recently, more evidence demonstrates that Axin is
involved in many other signaling pathways, including mTOR14,
JNK MAPK15, parathyroid hormone16, and p53 signaling
[10,12,13].
Bacterial infection is a stress to the host. Pathogens use a type
three secretion system (TTSS) to inject bacterial pathogenic
proteins, called effectors, into host cells [14]. Virulence bacterial
effectors, such as Salmonella AvrA, mimic the activity of a
eukaryotic protein and debilitate their target cells [15]. Our
publications and those of others demonstrate that b-catenin/Wnt
[16,17,18,19,20,21,22], JNK/MAPK [15,23], and p53 [24] are
involved in bacterial infection and intestinal inflammation. Axin is
a key player for the b-catenin/Wnt, JNK and p53 pathways.
However, it is not known whether Axin directly regulates
Salmonella-induced inflammation in the intestine.
In this current study, we investigated the molecular mechanism
and physiological roles of Axin1-Salmonella interactions. We found
that pathogenic Salmonella colonization decreased the Axin1
protein expression in intestinal epithelial cells at the post-
transcriptional level. Bacterial protein AvrA expression stabilizes
Axin1 protein and beta-catenin/Axin interactions. Axin1 exhib-
ited a specific role in inhibiting Salmonella invasion and bacterial
inflammation. It is affected by the level of Axin1, but not Axin2.
The resulting data indicate an essential role of intestinal Axin1 in
modulating host defense against pathogen-induced inflammation.
Results
Axin1 responds to Salmonella treatment
To determine whether Axin protein plays a role in epithelial-
Salmonella interactions, we tested human intestinal epithelial
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34942HCT116 cells with wild-type (WT) Salmonella ATCC 14028s. We
found that WT Salmonella significantly decreased the total amount
of Axin1 in host cells after bacterial colonization for only 1 hour
(Fig. 1A. HCT116). To look at the generality of our observation,
we further investigated the response in the human colonic
epithelial cell lines HT29C19A and CaCo2BBE. We had to use
these cell lines because there is no non-cancer and non-
transformed colon cell line available in the field. A similar change
in Axin1 reduction by pathogenic WT Salmonella was found
(Fig. 1A). To test if the response is specific to Salmonella, we also
treated cells with inflammatory cytokine TNF-a, human com-
mensal bacterial E. coli F18, and probiotic strain Lactobacillus
rhamnosus GG (Fig. 1B). However, we did not see the similar
alternation of Axin1. Furthermore, we found that the Salmonella-
induced Axin1 reduction occurred in a time-dependent manner.
WT Salmonella colonization of the cells for only 30 minutes was
able to decrease Axin protein expression, and the effect could last
for more than 60 minutes (Fig. 1C).
Using RT-PCR, we investigated Axin mRNA expression in
intestinal epithelial cells. The transcriptional levels of Axin1 and 2
were not significantly changed by WT Salmonella in vitro (Fig. S1A
and B). Overall, our data showed that pathogenic Salmonella
reduces Axin1 protein.
Reduction of Axin1 protein in the Salmonella-infected
mouse intestine in vivo
Although cell lines provide useful information about the effects
of Salmonella on Axin1 expression, these models lack the structural
and biological relationships that exist in vivo. Therefore, we
determined whether bacteria modulate Axin1 expression in
streptomycin-pretreated C57BL6 mice colonized with bacterial
strains. Streptomycin treatment is known to diminish the intestinal
flora and to render mice susceptible to intestinal colonization by
various microorganisms. In previous studies, we have established
the streptomycin-pretreated Salmonella-colitis mice to understand
the host-pathogen interactions [19,20]. Post infection 8 hours is
correlated with the early stage of in vitro bacterial colonization.
Here, we found that Axin1 protein was significantly reduced by
pathogenic Salmonella 8 hours postinfection, the early stage of
infection in vivo (Fig. 1D). Additionally, the Axin1 mRNA level was
not changed by Salmonella infection in vivo (Fig. S1C).
Axin1 protein synthesis and degradation in epithelial
cells colonized with Salmonella
To explore the molecular mechanism of Salmonella-induced Axin
1 reduction, we tested Axin1 protein synthesis using cycloheximide
(CHX). CHX is an inhibitor of eukaryotic protein biosynthesis and
is commonly used to determine protein half-life. Cells were treated
with CHX; Axin1 protein synthesis was reduced after 4 hours of
treatment without Salmonella (Fig. 2A). In contrast, Axin1 was
dramatically reduced to 40% 2 hours after CHX and Salmonella
treatment. A line chart further shows that the level of Axin1
protein synthesis was higher in untreated cells than in the
Salmonella-treated cells. Hence, the rate of Axin1 degradation is
faster in Salmonella-treated cells (Fig. 2A).
Axin1 is regulated by Salmonella at the post-translational
level
Because Axin protein destabilization occurred in the early stage
of Salmonella invasion, we hypothesized that Axin1 was regulated at
the post-transcriptional level upon Salmonella stimulation. It is
known that Axin is phosphorylated and ubiquitinated and then is
degraded by the proteasome [25]. Hence, we investigated whether
Salmonella reduced Axin protein through increased ubiquitination.
By Western blot assay, ubiquitinated protein appears as a smear of
bands above the regular band of the target protein. We treated
epithelial cells with Salmonella and tested Axin expression and
ubiquitination using immunoprecipitation. Our data indicated
that Salmonella treatment induced more ubiquitinated Axin1
compared to control cells. The ubiquitinated Axin1 (Ub-Axin)
was enhanced after Salmonella colonization for 60 minutes (Fig. 2B).
Recent studies demonstrated that Axin is also regulated through
SUMOylation [13,25,26]. We tested Axin1 SUMOylation in the
Salmonella-treated epithelial cells. We found that the SUMOylated
Axin1 was enhanced by treatment with WT Salmonella (Fig. 2C).
To determine whether Axin1 reduction occurs through
increased proteasome degradation, cells were treated with the
proteasome inhibitor MG262. In the presence of MG262, the level
of Axin1 protein was comparable to that of the control cells
(Fig. 2D). Taken together, these data showed that increased
ubiquitination, SUMOylation, and proteasome degradation of
Axin1 occurs during Salmonella infection.
The amino acids specifically required for Salmonella-
induced Axin1 degradation
To explore the molecular mechanism of Axin1 degradation in
Salmonella-infected cells, we established an Axin overexpression
system using HCT116 cells transiently transfected with a c-myc-
tagged Axin1 protein (Fig. S2A). A sketch of the generated Axin1
mutations is shown in Fig. 3A. Axin1 contains a canonical
regulator of G protein signaling (RGS) core domain and a DIX
domain [8,27]. We tested the Axin1 levels and its stabilization
using these Axin1 mutants. We found that the levels of Axin1
DRGS domain mutant were significantly reduced after Salmonella
infection (Fig. 3B). In contrast, the level of Axin1DDIX did not
decrease after Salmonella infection. In addition, the Axin1 DRGS
DDIX double mutation lost the target domain, and its protein level
was not reduced by Salmonella infection. Moreover, IP data
indicated that there was no change in Axin SUMOylation after
Salmonella infection in cells transfected with Axin1 DDIX (Fig. 3C).
In contrast, the SUMOylation of Axin DRGS was still enhanced
by Salmonella.
We further tested whether Salmonella exploited Axin1 at key
amino acid sites that regulate ubiquitination and SUMOylation.
The Axin1S614A mutant lost its ability to be ubiquitinated and
was not degraded by Salmonella (Fig. 3D). IP data indicated that
Salmonella treatment did not change the ubiquitination of AvrA
S614A, whereas K954A ubiquitination was enhanced by Salmonella
(Fig. 3E). Moreover, Salmonella infection did not enhance
Axin1S164A SUMOylation, whereas SUMOylation of Axin
K954A was still high (Fig. 3F). We also tested the other Axin1
mutations (Fig. S3A); however, the protein levels of these Axin1
mutants did not change after Salmonella infection (Fig. S3B–D).
Taken together, our data suggested that Salmonella targeted the
DDIX domain of Axin1 and ser614 to reduce Axin1 protein level
during host-bacterial interactions.
We also tested the function of Axin2 in the HCt116 cells.
However, transfected Axin2 did not change after Salmonella
treatment (Fig. S2C). In contrast, both endogenous Axin1 and
exogenous c-myc tagged Axin1 decreased cells treated with WT
Salmonella (Fig. S2B).
Decreased b-catenin/Axin binding in Salmonella
colonized cells
Axin can interact with many proteins in the cell [8]. It forms a
complex with GSK-3b and b-catenin and promotes GSK-3b-
Bacteria and Axin1 in Inflammation
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tation and western blot, we found that WT Salmonella decreased
the amount of Axin1 in a complex with b-catenin, whereas the
binding between Axin1 and b-catenin was not altered by PhoP
C
colonization (Fig. 4A). Densitometry analysis showed significant
decreases in the binding of Axin1 and b-catenin after WT
Salmonella colonization.
We also tested another Axin/b-catenin-associated protein,
GSK-3b (Fig. 4B). The total amount of Axin bound to GSK-
3bwas also reduced by WT Salmonella, whereas PhoP
c colonization
stabilized the Axin/GSK-3b interaction within the cell. Further-
more, densitometry analysis showed a significant reduction of
Axin/GSK-3b interaction induced by WT Salmonella.
WT Salmonella also reduced the amount of APC/Axin-binding
proteins, whereas levels of the APC/b-catenin complex were not
significantly changed after Salmonella infection (Fig. 4C). Taken
together, these IP data indicated that pathogenic Salmonella
colonization reduces Axin1 in the intestinal epithelial cells, thereby
decreasing the dynamic interaction between Axin and its binding
partners.
Axin1 protein protects cells from Salmonella invasion
For the physiological relevance of Axin involved in the
Salmonella-host interactions, a green-fluorescence-tagged Salmonella
strain was used to detect bacterial invasion in intestinal epithelial
cells. There was less green Salmonella in the cells with Axin1
overexpression compared to the normal cells (Fig. 5A). We further
counted the numbers of Salmonella invading the HCT116 cells with
normal or over-expressed Axin1 protein. We found that Axin1-
over-expressing epithelial cells had less internalized Salmonella than
control cells with regular Axin1 expression (Fig. 5B). We also
examined the number of cell-associated bacteria, including
bacteria adhered to and/or internalized into the epithelial
Figure 1. Pathogenic Salmonella decreases Axin 1 protein expression in host cells. (A) Axin1 protein expression in human epithelial cell
lines. Cells were incubated with S. typhimurium wild-type (WT) for 30 minutes, washed, and incubated in fresh DMEM for 1 hour. Total cell lysates
were analyzed for total Axin1 levels by immunoblot. *P,0.05. n=3 separate experiments. (B) Inflammatory cytokine TNF-a, commensal bacterial E.
coli F18, and probiotics LGG did not alter Axin1 protein expression in HCT116 cells. (C) Salmonella decreases Axin1 protein expression at the early
stage of colonization in HCT116 cells. (D) Axin1 reduction by pathogenic Salmonella WT in intestinal epithelial cells in vivo. Salmonella decreases
Axin1 protein expression in the mouse large intestine after bacterial infection in vivo. Data are expressed as mean 6 SD.* P,0.05. n=3 mice/group.
doi:10.1371/journal.pone.0034942.g001
Bacteria and Axin1 in Inflammation
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34942monolayers. Axin1 expression did not change the number of
associated Salmonella in the host cells (Fig. S4A).
We also investigated the distribution of Axin1. Immunostaining
data showed that Axin1 protein was dispensed diffusely in the
cytoplasm in HCT116 cells without bacterial treatment. Post-
pathogenic Salmonella infection, Axin1 was scattered as dots in the
cytoplasm. Some Axin1 relocated to the cell membrane (Fig. 5C).
Axin1 relocation to the cell membrane may help to block the
bacterial invasion.
The DIX domain is required for Axin1’s function in
inhibiting bacterial invasion
We investigated the effect of Axin1 mutations on bacterial
invasion. As shown in Fig. 5D, cells with DRGS overexpression
had less invaded Salmonella, whereas DDIX-expressing cells had a
significantly higher amount of Salmonella invasion. Axin1 mutations
did not change the number of bacteria associated with the
epithelial cells (Fig. S4B). Taken together, these data further
indicate that Axin1DDIX was targeted by Salmonella. Therefore,
the mutated Axin1DDIX could not protect cells from bacterial
invasion. However, Axin2 did not have any effects on Salmonella
attachment and invasion (Fig. S5A & 5B).
Axin1 protein is directly involved in Salmonella-induced
inflammation
We reasoned that Axin1 expression could protect cells from
Salmonella-induced inflammation. We tested the inflammatory
response of IL-8 in cells overexpressing Axin1. Upon Salmonella
colonization, IL-8 mRNA expression decreased in cells overex-
pressing Axin1 compared to normal HCT116 cells (Fig. 6A). We
also found that the IL-8 protein secretion was significantly lower in
cells overexpressing Axin1 (Fig. 6B). In addition, Axin2 overex-
pression did not have any effect on the expression of Salmonella-
induced IL-8 at either the transcriptional (data not shown) or the
translational level (Fig. S5C).
To further investigate the molecular mechanisms, we blocked
Axin1 expression using siRNA. As shown in Fig. 6C–D, the
knockdown of Axin1 significantly enhanced IL-8 mRNA expres-
sion and IL-8 protein secretion in the cell culture media compared
with cells without treatment or with control siRNA. Moreover, the
cells overexpressing Axin DRGS produced significantly less IL-8,
whereas cells overexpressing DDIX had higher IL-8 secretion
induced by Salmonella (Fig. 6E). Taken together, our data indicate
that WT Axin1 plays a protective role in bacterial intestinal
inflammation. The DIX domain is required for Axin1’s functions.
Discussion
In the current study, we showed that Axin1, but not Axin2,
plays an important role in inhibiting bacterial invasion and
inflammation in intestinal epithelial cells. The reduction of Axin1
occurred at an early stage of Salmonella infection (Fig. 6F). Axin1
protein was modified by Salmonella-colonization through ubiquiti-
nation and SUMOylation. Our findings further demonstrated that
the protein expression level of Axin may determine the host’s
Figure 2. Axin1 reduction by Salmonella is through ubiquitina-
tion and SUMOylation. (A) Protein synthesis of Axin 1 is low in
Salmonella-treated cells. (B) Ubiquitination of Axin1 increased in the
Salmonella-colonized cells. (C) Sumoylation of Axin1 increased in the
Salmonella-colonized cells. (D) Proteasome inhibitor MG262 stabilized
Axin1 protein after Salmonella colonization. Cells treated with MG262
(20 mM) for 2 hours had increased levels of Axin1 protein. Data are
expressed as mean 6 SD. * P,0.05. n=3 separate experiments.
doi:10.1371/journal.pone.0034942.g002
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significantly lower in cells with Axin overexpression compared to
those in the normal intestinal epithelial cells. In contrast, when
Axin1 was knockdown, Salmonella induced significantly higher level
of IL-8 expression. Axin1DDIX domain and ser164A is specifically
required for Salmonella-induced degradation of Axin1. Although
Axin 1 and 2 are functionally equivalent in developmental settings
[28,29,30], a distinct biological function of Axin1 and 2 was
identified in host defense. We reported that Axin2 was not
involved in inhibiting bacterial invasion and inflammation,
whereas Axin1 plays a protective role for host defense against
pathogenic bacteria.
Our previous studies demonstrated that Wnt/b-catenin is
involved in Salmonella-induced intestinal inflammation
[19,20,21,22,31]. Classically, Axin1 is viewed as a negative
regulator of the Wnt/b-catenin pathway in development and
cancer. The degradation of Axin1 leads to activation of the Wnt/
b-catenin pathway. The binding between b-catenin and Axin is
modified by Salmonella colonization. This may further explain our
previous observation that the Wnt/b-catenin pathway is involved
in Salmonella-induced intestinal inflammation. In in vitro studies, we
used HCT116 cells with full length APC and HT29 and
Caco2BBE with truncated APC. We found that the length of
APC may influence the abundance of Axin1 in the cells. However,
it does not change the effect of Salmonella-induced downregulation
of Axin1. Recent studies demonstrate that Wnt/b-catenin
signaling is regulated through both Axin-dependent proteolysis
and Axin-independent proteolysis [32]. Hence, some of the effects
we observed, such as Axin1 overexpression inhibiting Salmonella
invasion, could be b-catenin-independent.
In Axin1 over-expressing cells, there was less Salmonella-induced
IL-8 secretion. This finding indicates that Axin1 expression can
protect cells from inflammation. Recently, studies have implied the
Wnt signaling in the activation of proinflammatory mediators in
inflammatory disorders [33]. Patients with inflammatory bowel
diseases (IBD) have significantly higher expression of Wnts
Figure 3. Salmonella target the Axin DIX domain and ubiquitination. (A) Diagrams of Axin1 constructs used in this study. (B) Protein levels of
wild-type Axin1, Axin1 DRGS, Axin1 DDIX, and Axin1 DRGS DDIX mutations in cells with or without Salmonella colonization. (C) Salmonella target the
DDIX mutations of Axin1 for SUMOlyation. (D) Axin1 mutants S614A and K954A had different responses to Salmonella colonization. Note that the
Axin1 mutant S614A was not reduced by Salmonella. Data are expressed as mean 6 SD. * P,0.05. n=3 separate experiments. (E) Ubiquitination of
AxinS614A did not increase in the Salmonella-colonized cells. (F) SUMOylation of Axin1 and its mutants S614A and K954 in the Salmonella-colonized
cells.
doi:10.1371/journal.pone.0034942.g003
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expression of the Wnt-signaling pathway transcription factor
TCF-4 in ileal Crohn’s disease [35]. However, some of these
studies have focused on the responses of monocytes to the
inflammatory cytokines in the immune system through Wnts [36].
The effects and molecular mechanisms of Axin, the key scaffold of
Wnt signaling, in regulating intestinal inflammation remain
unknown.
Axin1 has been shown to interact with many critical proteins,
including b-catenin, GSK3 b, LRP5, and DVL1 [25,37,38,39]. In
addition, Axin1 expression determines p53 activation in cell
development [12,40]. It is still unknown how Axin1 may
synergistically regulate multiple signaling pathways, thereby
altering the host response to bacterial infection. A limitation of
the current work is that we could not use whole Axin1 knockout
mice for further in vivo studies, because its phenotype in mice is
lethal. The Axin1 conditional mutant mice are available now [41],
we will focus on the physiological role of intestinal Axin in in vivo in
anti-inflammation and anti-infection for future studies.
In summary, the current study determines the protective role of
Axin1 in the Salmonella invasion and bacterial-induced inflamma-
tion. Our results indicate that a previously undefined role of Axin1
in host-pathogen interactions and inflammation.
Materials and Methods
Ethics statement
All animal work was approved by the University of Rochester
University Committee on Animal Resources (UCAR) committee
(UCAR 2007-065). If a mouse showed that it had aspirated fluid or
significant body weight loss (10% or more), and did not die
immediately, the mouse was humanely euthanized.
Bacterial strains and growth condition
Bacterial strains used in this study included Salmonella typhimurium
wild-type strain ATCC14028 (WT-SL) and non-pathogenic
Salmonella mutant strain PhoP
c [42]. Non-agitated microaerophilic
bacterial cultures were prepared as previously described [22].
Cell culture
Human colonic epithelial HCT116, CaCo2BBE, and
HT29C19A cells were maintained in DMEM supplemented with
10% fetal bovine serum (FBS), penicillin-streptomycin and L-
glutamine. The rat small intestinal IEC-18 cell line was grown in
DMEM (high glucose, 4.5 g/L) containing 5% FBS (vol/vol),
0.1 U/ml insulin, 50 mg/ml streptomycin, and 50 U/ml penicillin.
Streptomycin pre-treated mouse model
Animal experiments were performed using specific-pathogen-
free female C57BL/6 mice (Taconic, Hudson, NY) that were 6–7
weeks old, as previously described [20,43,44]. The protocol was
approved by the University of Rochester University Committee on
Animal Resources (UCAR). Water and food were withdrawn
Figure 4. Axin/b-catenin interaction in cells infected with
Salmonella. (A) Less Axin1 in a complex with b-catenin in cells infected
by WT Salmonella compared to cells without bacterial treatment or with
mutant Salmonella PhoPc. Data are expressed as mean 6 SD. * P,0.05.
n=3 separate experiments. (B) Decreased Axin1/GSK-3b interaction in
cells infected with WT Salmonella compared to cells without bacterial
treatment or with mutant Salmonella PhoPc. Data are expressed as
mean 6 SD. * P,0.05. n=3 separate experiments. (C) Reduced APC/
Axin1 interaction in cells infected by WT Salmonella compared to cells
without bacterial treatment or with PhoPc. Please note that the anti-
APC antibody pulled down the same amount of b-catenin in cells with
or without Salmonella colonization. It indicated that the APC/b-catenin
interaction was not altered by Salmonella. Data are expressed as mean
6 SD. * P,0.05. n=3 separate experiments.
doi:10.1371/journal.pone.0034942.g004
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(100 ml of sterile solution or 100 ml of sterile water in control).
Afterwards, animals were supplied with water and food ad libitum.
Twenty hours after streptomycin treatment, water and food were
withdrawn again for 4 hours before the mice were infected with
1610
7 CFU of S. Typhimurium (100 ml suspension in HBSS) or
treated with sterile HBSS (control). Eight hours after infection,
mice were sacrificed, and tissue samples from the intestinal tracts
were removed for analysis.
Mouse colonic epithelial cells
Mouse colonic epithelial cells were collected by scraping the
mouse colon, including the proximal and distal regions. Cells were
sonicated in lysis buffer (1% Triton X-100, 150 mM NaCl,
10 mM Tris pH 7.4, 1 mM EDTA, 1 mM EGTA pH 8.0,
0.2 mM sodium orthovanadate, protease inhibitor cocktail). The
protein concentration was measured using BioRad Reagent
(BioRad, Hercules, CA, USA).
Transient transfections
Plasmids with c-myc-tagged, wild-type Axin1, Axin2, and Axin1
mutants were from Dr. Hsu’s laboratory. Transient transfections
were performed with Lipofectamine2000 (Invitrogen, San Diego,
CA) in accordance with the manufacturer’s instructions. At the
indicated times after transfection, proteins were extracted with
RIPA buffer (50 mM Tris-Hcl, pH 8.0 with 150 mM sodium
chloride, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) for
immunoblotting.
Axin1 siRNA
HCT116 cells were grown in 12-well plates. The cells were
transfected with on-Target plus smart pool human Axin 1 siRNA
(Dharmacon Inc., Lafayette, MO) or scrambled siRNA control
(Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) using
Surefect reagent (SABiosciences, Frederick, MD). After transfec-
tion for 72 hours, cells were colonized by Salmonella for 30 min,
washed, and incubated for 30 min in DMEM with Gentamicin
(500 mg/ml), and then the levels of Axin and b-actin were assessed
by western blot.
Immunoblotting
Mouse epithelial cells were scraped and lysed in lysis buffer (1%
Triton X-100, 150 mM NaCl, 10 mM Tris pH 7.4, 1 mM
EDTA, 1 mM EGTA pH 8.0, 0.2 mM sodium orthovanadate,
protease inhibitor cocktail), and then the protein concentration
was measured. Cultured cells were rinsed twice in ice-cold HBSS,
lysed in protein loading buffer (50 mM Tris, pH 6.8, 100 mM
dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol),
and then sonicated. Equal amounts of protein were separated by
Figure 5. Physiologic function of Axin1 in host defense. (A)
Axin1 expression in intestinal epithelial cells changed bacterial invasion.
Cells overexpressing Axin1 were resistant to invasion of GFP-Salmonella
(Green). (B) Number of bacteria associated with intestinal epithelial cells
with different Axin1 levels. (C) Localization of Axin1 in the intestinal
epithelial cells before and after bacterial infection. HCT 116 cells
transfected with a c-myc-tagged Axin plasmid were colonized with
Salmonella. Immunostaining showed that Axinl protein localized to the
cell membrane and cytoplasm in HCT116 cells. Degraded Axin1 proteins
were shown as green dots in cells infected with Salmonella. (D) Number
of invasive bacteria in intestinal epithelial cells with different Axin1
mutations. Axin1 DDIX lost the effect to inhibit Salmonella invasion.
Data are expressed as mean 6 SD. * P,0.05. n=3 separate
experiments.
doi:10.1371/journal.pone.0034942.g005
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lose, and immunoblotted with primary antibodies. The following
antibodies were used: anti-Axin1 (Cell Signal, Beverly, MA,
U.S.A), anti-APC, anti-Villin,anti-c-Myc (Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, CA, U.S.A.), anti-ubiquitin (Enzo life
Science, 5120 Butler Pike Plymouth Meeting, PA, U.S.A.), anti-
Figure 6. Axin1 expression in the intestinal epithelial cells changes inflammatory responses. Transient transfections were performed
with Lipofectamine2000 (LF2000). (A) IL-8 mRNA in Axin1-overexpressing HCT116 cells after Salmonella colonization. (B) IL-8 protein secretion in cell
culture media in Axin1-overexpressing HCT116 cells after Salmonella colonization. (C) IL-8 mRNA in cells with Axin1 blockage by siRNA of Axin1
overexpression and IL-8 protein. (D) Salmonella-induced IL-8 protein levels in cells with Axin1 blockage by using siRNA against Axin1. (E) Salmonella-
induced IL-8 protein levels in cells with Axin1 mutations. Axin1 DDIX lost the effect to inhibit IL-8 secretion. Data are expressed as mean 6 SD. *
P,0.05. n=3 separate experiments. (F) A diagram showing the roles of the Axin1 pathway in intestinal epithelial-Salmonella interactions. From
bacterial side, Salmonella invasion induces degradation of Axin1 and dissociates Axin1/beta-catenin/APC complex in intestinal epithelial cells. From
the host side, cells with high expression level of Axin1 are able to inhibit Salmonella invasion and suppress inflammation. Axin1 plays a novel role in
host defense during bacterial-induced inflammation.
doi:10.1371/journal.pone.0034942.g006
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anti-b-catenin (1:1000; BD, San Jose, CA, U.S.A.), or anti-b-actin
(Sigma-Aldrich, Milwaukee, WI, U.S.A.) antibodies and were
visualized by ECL. Membranes that were probed with more than
one antibody were stripped before re-probing.
Coimmunoprecipitation assay
Cells were rinsed twice in ice-cold HBSS and lysed in cold
immunoprecipitation buffer (1% Triton X-100, 150 mM NaCl,
10 mM Tris?HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, pH 8.0,
0.2 mM sodium orthovanadate) containing protease inhibitor
cocktail. Samples were precleared with protein A-agarose. Pre-
cleared lysates were incubated with 2 mg of primary antibodies for
1 hour at 4uC. Protein A-agarose was added to the lysate and
incubated for 30 min with agitation at 4uC before being washed
with cold immunoprecipitation buffer. The pellet was resuspended
in 0.1 M glycine, pH 2.5, and incubated with agitation for 10 min
at 4uC and then centrifuged at 9,000 g for 2 minutes. The
supernatant was removed and neutralized with 1 M Tris?HCl,
pH 8.0. The samples were diluted with concentrated (56)
electrophoresis sample buffer (125 mM Tris, pH 6.8, 4% SDS,
10% glycerol, 0.006% bromophenol blue, 2% b-mercaptoetha-
nol), boiled for 5 minutes, separated by SDS-polyacrylamide gel
electrophoresis, and transferred onto a nitrocellulose membrane.
Membrane blots were probed with secondary antibody and
visualized by ECL.
Immunofluorescence
Colonic tissues from the proximal and distal portion of the colon
were freshly isolated and paraffin-embedded after fixation with
10% neutral buffered formalin. Immunofluorescence was per-
formed on paraffin-embedded sections (1 mm) of mouse colons.
After preparation of the slides as described previously [19], slides
were incubated in 3% hydrogen peroxide for 20 minutes at room
temperature to block endogenous peroxidase activity, followed by
incubation for 20 minutes in 5% BSA with 0.1% saponin in PBS
to reduce nonspecific background.
Cultured cells were rinsed three times in HBSS, fixed for
20 minutes in 100% cold ETOH, and permeabilized for
10 minutes with 0.2% Triton X-100, followed by three rinses
with Hanks HBSS, and incubation for 30 minutes in 10% BSA in
HBSS to reduce nonspecific background. The permeabilized cells
or tissue samples were incubated with primary antibodies for
90 minutes at room temperature. Samples were then incubated
with goat anti-rabbit Alexa Fluor 488 or goat anti-mouse Alexa
Fluor 594 (Molecular Probes, CA; 1:200) and DAPI (Molecular
Probes 1:10,000) for 1 hour at room temperature. Tissues or cells
were mounted with SlowFade (SlowFadeH AntiFade Kit, Molec-
ular Probes), followed by a coverslip, and the edges were sealed to
prevent drying. Specimens were examined with a Leica SP5 Laser
Scanning confocal microscope.
S. typhimurium invasion of human epithelial monolayers
Infection of HCT116 cells was performed by a previously
described method [44,45]. Bacterial solution was added, and
bacterial invasion was assessed after 30 minutes. Cell-associated
bacteria, representing bacteria adhered to and/or internalized into
the monolayers, were released by incubation with 100 ml1 %
Triton X-100 (Sigma). Internalized bacteria were those obtained
from lysis of the epithelial cells with 1% Triton X-100 30 minutes
after the addition of gentamicin (50 mg/ml). For both cell-
associated and internalized bacteria, 0.9 ml LB broth was added,
and each sample was vigorously mixed and quantitated by plating
for CFU on MacConkey agar medium.
Salmonella-induced human IL-8 secretion
HCT116 cells were cultured in DMEM, followed by Salmonella-
containing HBSS for 30 minutes, washed 3 times in HBSS, and
incubated at 37uC for 6 hours. Cell supernatants were removed
and assayed for IL-8 by ELISA in 96-well plates.
Real Time quantitative PCR
Total RNA was extracted from epithelial cell monolayers or
mouse colonic epithelial cells using TRIzol reagent (Invitrogen,
Carlsbad, CA). The RNA integrity was verified by gel electro-
phoresis. RNA reverse transcription was done using the iScript
cDNA synthesis kit (Bio-Rad, Hercules, CA) according to the
manufacturer’s directions. The RT-cDNA reaction products were
subjected to quantitative real-time PCR using the MyiQ single-
color real-time PCR detection system (Bio-Rad) and iQ SYBR
green supermix (Bio-Rad) according to the manufacturer’s
directions. All expression levels were normalized to b-actin levels
of the same sample. Percent expression was calculated as the ratio
of the normalized value of each sample to that of the
corresponding untreated control cells. All real-time PCR reactions
were performed in triplicate. All PCR primers were designed using
Lasergene software (Table 1) (DNAStar, Madison, WI).
Statistical Analysis
Data are expressed as mean 6 SD. Differences between two
samples were analyzed by Student’s t test. P-values of 0.05 or less
were considered statistically significant. Differences among three
or more groups were analyzed using ANOVA (SAS 9.2 version,
SAS Institute Inc., Cary, NC).
Supporting Information
Figure S1 Pathogenic Salmonella decreases Axin 1
protein expression but not mRNA expression in the host
cells.
(PDF)
Figure S2 Salmonella reduces Axin1 expression through
ubiquitination and SUMOylation.
(PDF)
Table 1. Real-Time PCR Primers.
Gene name Primers
Human Axin1-F CCTGTGGTCTACCCGTGTCT
Human Axin1-R GCTATGAGGAGTGGTCCAGG
Human Axin2-F CTGGCTTTGGTGAACTGTTG
Human Axin2-R AGTTGCTCACAGCCAAGACA
Mouse Axin1-F ACGGTACAACGAAGCAGAGAGCT
Mouse Axin1-R CGGATCTCCTTTGGCATTCGGTAA
Mouse Axin2-F GAGTAGCGCCGTGTTAGTGACT
Mouse Axin2-R CCAGGAAAGTCCGGAAGAGGTATG
Human IL8-F TGCATAAAGACATACTCCAAACCT
Human IL-8R AATTCTCAGCCCTCTTCAAAAA
Human b-actin-F AGAGCAAGAGAGGCATCCTC
Human b-actin-R CTCAAACATGATCTGGGTCA
Mouse b-actin-F TGTTACCAACTGGGACGACA
Mouse b-actin-R CTGGGTCATCTTTTCACGGT
doi:10.1371/journal.pone.0034942.t001
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mutants in cells with or without Salmonella coloniza-
tion.
(PDF)
Figure S4 Axin1 expression in the intestinal epithelial
cells did not change bacterial association.
(PDF)
Figure S5 Axin2 expression in the intestinal epithelial
cells did not change bacterial infection and inflamma-
tory responses.
(PDF)
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